ConductScience.org, home

Paper42964321PubMed

Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial.

Gágyor I and 15 others. EClinicalMedicine, 2026.

Cite this record

ConductScience Library. Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial. Papers, record 42964321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42964321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Low-dose prednisolone and B vitamins for post-COVID-19 syndrome in Germany: the PreVitaCOV randomised clinical trial.
Journal
EClinicalMedicine
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-01

Source PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gágyor IIldikó
2Klug AAndreas
3Schwager AAlexander
4Gelbrich GGötz
5Joos SStefanie
6Fießler CCornelia
7Haeusler KGKarl Georg
8Lunden LLaura
9Escales CCatharina
10Döhring JJuliane
11Kutterer CCeline
12Kaußner YYvonne
13Maetzler WWalter
14Zolk OOliver
15Förster CChristian
16Kaduszkiewicz HHanna

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05638633Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-SyndromeDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140188838Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial.Lancet Infect Dis2025https://conductscience.org/library/papers/40188838PubMed
231664536Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease.J Patient Rep Outcomes2019https://conductscience.org/library/papers/31664536PubMed
326931289Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples.J Clin Epidemiol2016https://conductscience.org/library/papers/26931289PubMed
432398306The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19.Eur Respir J2020https://conductscience.org/library/papers/32398306PubMed
521479777Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).Qual Life Res2011https://conductscience.org/library/papers/21479777PubMed
634730322Systemic corticosteroids for management of 'long-COVID': an evaluation after 3 months of treatment.Monaldi Arch Chest Dis2021https://conductscience.org/library/papers/34730322PubMed
720685078The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.J Clin Epidemiol2010https://conductscience.org/library/papers/20685078PubMed
825935353Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients.Qual Life Res2015https://conductscience.org/library/papers/25935353PubMed
936215063Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.JAMA2022https://conductscience.org/library/papers/36215063PubMed
108463991Development of a fatigue scale.J Psychosom Res1993https://conductscience.org/library/papers/8463991PubMed
1141911553The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.Ann Intern Med2026https://conductscience.org/library/papers/41911553PubMed
1239096925Long COVID: a clinical update.Lancet2024https://conductscience.org/library/papers/39096925PubMed
1334247326Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.Qual Life Res2021https://conductscience.org/library/papers/34247326PubMed
1439603702Interventions for the management of long covid (post-covid condition): living systematic review.BMJ2024https://conductscience.org/library/papers/39603702PubMed
1536969241Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.Front Immunol2023https://conductscience.org/library/papers/36969241PubMed
1636349400Clinical trials on the pharmacological treatment of long COVID: A systematic review.J Med Virol2023https://conductscience.org/library/papers/36349400PubMed
179757853Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.JAMA1998https://conductscience.org/library/papers/9757853PubMed
1831490017B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin.CNS Neurosci Ther2020https://conductscience.org/library/papers/31490017PubMed
199989716Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.Lancet1999https://conductscience.org/library/papers/9989716PubMed
2026952842PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.J Clin Epidemiol2016https://conductscience.org/library/papers/26952842PubMed

See all 39 referencesDownload CSV of references

Drugs4

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
PREDNISOLONECHEMBL131Derived from the trial1https://conductscience.org/library/drugs/CHEMBL131ChEMBL
PYRIDOXINECHEMBL1364Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1364ChEMBL
THIAMINECHEMBL1588Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1588ChEMBL
VITAMIN B12CHEMBL2375172Derived from the trial1https://conductscience.org/library/drugs/CHEMBL2375172ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42964321

GET https://conductscience.org/api/papers/v1/42964321/references?page=2